PTGS2 and colon carcinoma: These results support the involvement of COX-2 in the malignant behaviour of human colon carcinoma cells and underline the relevance of a stable virus-based COX-2 knockdown mediated by RNAi in order to impair the invasive and metastatic ability of CRC.